Sorin opens ACCESS training center in Clamart

NewsGuard 100/100 Score

Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today the opening of its Advanced Center for Continuous Education on Scientific Solutions - ACCESS - training center in Clamart (Paris). This state-of-the-art training center conducts quality training through lectures, peer-to-peer education and hands-on experience workshops.

ACCESS offers a comprehensive series of education modules for heart rhythm specialists, electrophysiology fellows, cardiologists and allied healthcare professionals. The training courses are delivered by internationally recognized experts who have a passion to share their knowledge. In this unique multicultural environment, members benefit from exchanging best in-clinic practices and enjoy productive, enriching peer-to-peer interactions.

As an educational partner of the European Heart Rhythm Association (EHRA), Sorin pays special attention to the quality of ACCESS educational and training contents.

"With all the new developments in the medical device industry, it is important that Sorin partners with dedicated medical professionals to help drive continuous learning," said Hein Heidbüchel, MD PhD, University Hospital Gasthuisberg, Leuven, Belgium and Chair of the EHRA (European Heart Rhythm Association) Educational Committee.

"ACCESS will not only host our CRM customers, but all cardiac health professionals across our three therapeutic areas will benefit from its advanced facilities," commented Stefano Di Lullo, Sorin Group, President of the CRM Business Unit. "The opening of ACCESS is another testimonial of our commitment to provide best in class clinical and technical training, and to assist medical professionals in their pursuit of excellence in patient care."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bidirectional Mendelian randomization uncovers link between plasma metabolites and heart attack risk